← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity

CTHR logoCharles & Colvard, Ltd.(CTHR)Earnings, Financials & Key Ratios

CTHR•NASDAQ
$0.10
$304032 mkt cap·Price updated May 1, 2026
SectorConsumer CyclicalIndustryLuxury GoodsSub-IndustryLuxury Jewelry and Watches
AboutCharles & Colvard, Ltd. operates as a fine jewelry company in the United States and internationally. The company manufactures, markets, and distributes moissanite jewels and finished moissanite jewelry under the Charles & Colvard Created Moissanite brand; and premium moissanite gemstones under the Forever One brand name. It also markets and distributes lab grown diamonds, and finished jewelry with lab grown diamonds under the Caydia brand. The company sells its products at wholesale prices to distributors, manufacturers, retailers, and designers; and to end-consumers at retail prices through charlesandcolvard.com, third-party online marketplaces, drop-ship, and other e-commerce outlets. Charles & Colvard, Ltd. was founded in 1995 and is headquartered in Morrisville, North Carolina.Show more
  • Revenue$22M-26.7%
  • EBITDA-$15M-11.0%
  • Net Income-$14M+26.6%
  • EPS (Diluted)-4.73+26.7%
  • Gross Margin23.65%+49.6%
  • EBITDA Margin-67.37%-51.4%
  • Operating Margin-66.52%-42.5%
  • Net Margin-65.42%
  • ROE-43.91%-11.4%
  • ROIC-37.66%-43.4%
  • Debt/Equity0.17+133.4%
  • Interest Coverage-253.06
Technical→

CTHR Key Insights

Charles & Colvard, Ltd. (CTHR) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Trading at only 0.0x book value

✗Weaknesses

  • ✗Negative free cash flow
  • ✗Weak momentum: RS Rating 4 (bottom 4%)
  • ✗Sales declining 7.4% over 5 years
  • ✗Trading more than 30% below 52-week high

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

CTHR Price & Volume

Charles & Colvard, Ltd. (CTHR) stock price & volume — 10-year historical chart

Loading chart...

CTHR Growth Metrics

Charles & Colvard, Ltd. (CTHR) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-2.57%
5 Years-7.4%
3 Years-17.59%
TTM-33.51%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM34.57%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM35.71%

Return on Capital

10 Years-11.67%
5 Years-13.6%
3 Years-21.54%
Last Year-42.54%

CTHR Peer Comparison

Charles & Colvard, Ltd. (CTHR) competitors in Luxury Jewelry and Watches — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
SIG logoSIGSignet Jewelers LimitedDirect Competitor3.54B87.53-100%
LOVE logoLOVEThe Lovesac CompanyDirect Competitor230.39M15.7822.87-2.8%1.87%6.53%0.85
CPRI logoCPRICapri Holdings LimitedProduct Competitor2.3B19.29-1.93-13.57%-466.67%8.34
FOSL logoFOSLFossil Group, Inc.Product Competitor260.26M4.46-3.08-12.28%-7.8%-70.99%3.25
BRLT logoBRLTBrilliant Earth Group, Inc.Product Competitor216.25M1.41-5.643.63%-0.83%-3.99%0.48
RGS logoRGSRegis CorporationSupply Chain65.41M26.850.613.52%48.86%60.44%1.89
WWW logoWWWWolverine World Wide, Inc.Supply Chain1.41B17.250.196.8%5.06%17.68%1.22
AOUT logoAOUTAmerican Outdoor Brands, Inc.Supply Chain145.48M9.55-1591.6710.55%-4.78%-5.76%0.19

Compare CTHR vs Peers

Charles & Colvard, Ltd. (CTHR) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs SIG

Most directly comparable listed peer for CTHR.

Scale Benchmark

vs AMZN

Larger-name benchmark to compare CTHR against a more recognizable public peer.

Peer Set

Compare Top 5

vs SIG, LOVE, CPRI, FOSL

CTHR Income Statement

Charles & Colvard, Ltd. (CTHR) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
Line itemDec'15Dec'16Dec'17Jun'19Jun'20Jun'21Jun'22Jun'23Jun'24TTM
Sales/Revenue30.77M29.17M27.03M32.24M29.19M39.24M43.09M29.95M21.96M15.75M
Revenue Growth %19.99%-5.2%-7.32%19.28%-9.47%34.42%9.82%-30.5%-26.68%-33.51%
Cost of Goods Sold20.55M20.4M15.47M17.35M21.2M20.81M22.85M25.21M16.76M13.1M
COGS % of Revenue66.8%69.94%57.23%53.82%72.63%53.04%53.02%84.19%76.35%-
Gross Profit
10.21M▲ 0%
8.77M▼ 14.2%
11.56M▲ 31.9%
14.89M▲ 28.8%
7.99M▼ 46.4%
18.43M▲ 130.6%
20.24M▲ 9.9%
4.73M▼ 76.6%
5.19M▲ 9.7%
2.64M▲ 0%
Gross Margin %33.2%30.06%42.77%46.18%27.37%46.96%46.98%15.81%23.65%16.78%
Gross Profit Growth %33.92%-14.17%31.89%28.8%-46.35%130.65%9.86%-76.62%9.69%-
Operating Expenses19.76M12.59M12.17M12.63M14.3M12.92M17.37M18.71M19.8M14.63M
OpEx % of Revenue64.24%43.15%45.02%39.16%49.01%32.92%40.31%62.48%90.17%-
Selling, General & Admin19.75M12.58M12.17M12.62M14.3M12.92M17.37M18.71M18.32M13.15M
SG&A % of Revenue64.18%43.14%45.01%39.15%49.01%32.92%40.31%62.48%83.45%-
Research & Development17.8K2.85K3.71K2.07K000000
R&D % of Revenue0.06%0.01%0.01%0.01%------
Other Operating Expenses000-1300001.47M1000K
Operating Income
-9.55M▲ 0%
-3.94M▲ 58.8%
-608.54K▲ 84.5%
2.27M▲ 472.3%
-6.32M▼ 378.8%
5.51M▲ 187.2%
2.87M▼ 47.8%
-13.98M▼ 586.4%
-14.61M▼ 4.5%
-11.98M▲ 0%
Operating Margin %-31.04%-13.5%-2.25%7.03%-21.64%14.04%6.67%-46.67%-66.52%-76.1%
Operating Income Growth %-5.59%58.78%84.54%472.29%-378.77%187.21%-47.84%-586.43%-4.51%-
EBITDA-8.69M-3.38M-186.53K2.75M-5.83M6.08M3.35M-13.32M-14.79M-11.6M
EBITDA Margin %-28.23%-11.59%-0.69%8.52%-19.96%15.48%7.78%-44.49%-67.37%-73.63%
EBITDA Growth %-9.46%61.1%94.48%1572.65%-312.08%204.28%-44.82%-497.4%-11.02%35.22%
D&A (Non-Cash Add-back)863.35K557.39K422.02K481.32K490.24K567.12K479.31K653.16K-185.28K388.71K
EBIT-5.06M-3.94M-425.33K2.28M-6.16M6.49M2.87M-13.68M-14.42M-11.83M
Net Interest Income-10.35K-1.74K-5418.82K157.21K-3.37K19.28K297.26K243K16.16K
Interest Income110011.02K158.09K5.58K19.28K297.26K300.72K154.45K
Interest Expense10.36K1.74K5412.2K8848.95K0057.72K138.3K
Other Income/Expense-10.22K-1.74K182.68K8.47K155.38K970.35K19.24K297.26K243K16.16K
Pretax Income
-9.56M▲ 0%
-3.94M▲ 58.8%
-425.87K▲ 89.2%
2.27M▲ 634.0%
-6.16M▼ 370.9%
6.48M▲ 205.2%
2.89M▼ 55.4%
-13.68M▼ 572.9%
-14.36M▼ 5.0%
-11.97M▲ 0%
Pretax Margin %-31.07%-13.5%-1.58%7.05%-21.11%16.51%6.71%-45.68%-65.42%-76%
Income Tax12.82K13.48K27.61K-1.44K1.73K-6.33M518.53K5.9M00
Effective Tax Rate %-0.13%-0.34%-6.48%-0.06%-0.03%-97.75%17.93%-43.15%0%0%
Net Income
-9.57M▲ 0%
-4.53M▲ 52.7%
-453.48K▲ 90.0%
2.28M▲ 601.8%
-6.16M▼ 370.8%
12.81M▲ 307.9%
2.37M▼ 81.5%
-19.58M▼ 924.8%
-14.36M▲ 26.6%
-11.97M▲ 0%
Net Margin %-31.11%-15.52%-1.68%7.06%-21.11%32.65%5.51%-65.39%-65.42%-76%
Net Income Growth %26.91%52.72%89.98%601.78%-370.81%307.9%-81.47%-924.83%26.65%34.57%
Net Income (Continuing)-5.09M-3.95M-453.48K2.28M-6.16M12.81M2.37M-19.58M-14.36M-11.97M
Discontinued Operations0000000000
Minority Interest0000000000
EPS (Diluted)
-2.50▲ 0%
-1.90▲ 24.0%
-0.39▲ 79.5%
1.00▲ 356.4%
-2.20▼ 320.0%
4.20▲ 290.9%
0.76▼ 81.9%
-6.45▼ 948.7%
-4.73▲ 26.7%
-3.84▲ 0%
EPS Growth %61.54%24%79.47%356.41%-320%290.91%-81.9%-948.68%26.67%35.71%
EPS (Basic)-2.49-1.89-0.361.04-2.154.400.78-6.45-4.73-
Diluted Shares Outstanding2.04M2.09M2.13M2.21M2.86M3.02M3.13M3.04M3.03M3.12M
Basic Shares Outstanding3.83M2.38M1.95M2.28M2.8M3.05M3.04M3.04M3.03M3.12M
Dividend Payout Ratio----------

CTHR Balance Sheet

Charles & Colvard, Ltd. (CTHR) balance sheet — assets, liabilities & shareholders' equity

Line itemDec'15Dec'16Dec'17Jun'19Jun'20Jun'21Jun'22Jun'23Jun'24TTM
Total Current Assets24.38M20.67M20.15M27.87M23.91M35.76M35.86M24.58M18.82M9.04M
Cash & Short-Term Investments11.11M7.43M4.59M12.47M13.99M21.3M15.67M10.45M4.14M1.26M
Cash Only11.11M7.43M4.59M12.47M13.99M21.3M15.67M10.45M4.14M1.26M
Short-Term Investments0000000000
Accounts Receivable2.23M2.79M3.38M1.96M670.72K1.91M2.47M630.09K1.09M707.43K
Days Sales Outstanding26.4434.9745.622.218.3917.7920.937.6818.222.8
Inventory10.12M9.77M11.21M11.91M7.44M11.45M11.02M7.48M7.51M5.95M
Days Inventory Outstanding179.75174.8264.45250.52128.15200.83176.13108.23163.45176
Other Current Assets7500303.69K820.06K913.2K144.63K5.51M5.66M6.08M1.13M
Total Non-Current Assets17.45M19.83M21.08M23.28M25M29.16M33.34M24.31M22.16M11.02M
Property, Plant & Equipment1.32M1.39M1.24M1.03M1.58M4.83M4.69M4.67M4.32M3.37M
Fixed Asset Turnover23.35x20.97x21.76x31.42x18.44x8.13x9.19x6.41x5.08x4.08x
Goodwill0000000000
Intangible Assets5.56K8.81K8.6K97.37K170.15K209.66K265.73K305.7K370.19K383.41K
Long-Term Investments0000000000
Other Non-Current Assets16.13M18.43M19.83M22.15M23.24M17.77M22.54M19.33M17.47M28.72M
Total Assets
41.83M▲ 0%
40.51M▼ 3.2%
41.23M▲ 1.8%
51.15M▲ 24.0%
48.9M▼ 4.4%
64.92M▲ 32.8%
69.21M▲ 6.6%
48.88M▼ 29.4%
40.98M▼ 16.2%
29.11M▲ 0%
Asset Turnover0.74x0.72x0.66x0.63x0.60x0.60x0.62x0.61x0.54x0.49x
Asset Growth %-11.44%-3.17%1.79%24.05%-4.38%32.75%6.6%-29.37%-16.17%-115.74%
Total Current Liabilities4.02M4.61M5.45M4.7M6.49M5.62M6.8M7.06M14.13M9.48M
Accounts Payable3.06M3.98M4.47M3.28M3.75M2.77M4.4M4.79M8.27M6.07M
Days Payables Outstanding54.3971.15105.3768.9864.5348.6670.3269.29180.15211.49
Short-Term Debt0000815.49K566.08K856.57K880.13K2.3M922.92K
Deferred Revenue (Current)00131.39K0794.74K774.89K452.87K566.9K0301.16K
Other Current Liabilities183K130.68K197.23K1.35M415.58K872.65K99.58K-434.17K2.65M2.31M
Current Ratio6.07x4.49x3.70x5.93x3.69x6.36x5.27x3.48x1.33x1.33x
Quick Ratio3.55x2.37x1.64x3.40x2.54x4.32x3.65x2.42x0.80x0.80x
Cash Conversion Cycle151.8138.61204.68203.7572169.96126.7446.621.5-12.69
Total Non-Current Liabilities1.08M1.03M925.12K729.58K982.95K3.61M2.85M2.05M1.2M534.92K
Long-Term Debt0000772K0000534.92K
Capital Lease Obligations0000203K3.6M2.85M2.05M1.2M2.19M
Deferred Tax Liabilities0000000000
Other Non-Current Liabilities1.08M1.03M925.12K729.58K7.95K9.88K0000
Total Liabilities5.1M5.64M6.37M5.43M7.47M9.23M9.65M9.11M15.33M10.02M
Total Debt00002.41M4.17M3.7M2.93M4.41M1.46M
Net Debt-11.11M-7.43M-4.59M-12.47M-11.58M-17.14M-11.96M-7.52M269K200.74K
Debt / Equity----0.06x0.07x0.06x0.07x0.17x0.17x
Debt / EBITDA-----0.69x1.10x---0.13x
Net Debt / EBITDA----4.54x--2.82x-3.57x---0.02x
Interest Coverage-921.91x-2266.45x-1124.85x1030.74x-7144.49x615.21x---253.06x-85.54x
Total Equity
36.73M▲ 0%
34.87M▼ 5.1%
34.86M▼ 0.0%
45.72M▲ 31.2%
41.44M▼ 9.4%
55.69M▲ 34.4%
59.56M▲ 6.9%
39.77M▼ 33.2%
25.65M▼ 35.5%
19.09M▲ 0%
Equity Growth %-10.92%-5.08%-0.03%31.16%-9.37%34.4%6.95%-33.22%-35.51%-149.56%
Book Value per Share18.0016.6616.3620.6814.4718.4219.0213.098.456.12
Total Shareholders' Equity36.73M34.87M34.86M45.72M41.44M55.69M59.56M39.77M25.65M19.09M
Common Stock54.24M54.24M54.24M54.34M54.34M56.06M57.24M57.24M67.23M67.23M
Retained Earnings-31.43M-33.66M-34.11M-33.11M-38.79M-25.98M-23.6M-43.18M-57.55M-64.19M
Treasury Stock000000-38.16K-489.98K-489.98K0
Accumulated OCI0-3.02M-3.45M0000000
Minority Interest0000000000

CTHR Cash Flow Statement

Charles & Colvard, Ltd. (CTHR) cash flow — operating, investing & free cash flow history

Line itemDec'15Dec'16Dec'17Jun'19Jun'20Jun'21Jun'22Jun'23Jun'24TTM
Cash from Operations1.57M2.21M-2.56M916.8K249.19K6.47M572.55K-3.88M-7.37M-7.37M
Operating CF Margin %5.1%7.57%-9.47%2.84%0.85%16.5%1.33%-12.94%-33.55%-
Operating CF Growth %-22.95%40.9%-215.9%135.81%-72.82%2497.71%-91.15%-776.81%-90.07%-2617.16%
Net Income-9.57M-3.95M-453.48K2.28M-6.16M12.81M2.37M-19.58M-14.36M-11.97M
Depreciation & Amortization863.35K557.39K422.02K481.32K490.24K567.12K479.31K653.16K703.37K954.93K
Stock-Based Compensation1.77M959.13K443.48K502.81K459.54K352.58K774.34K249.43K237.74K81.07K
Deferred Taxes00748K00-6.35M498.93K5.85M00
Other Non-Cash Items346.34K-1.2M-183.22K524.33K5.83M-860.45K120.72K6.07M1.21M-6.22M
Working Capital Changes8.16M5.84M-3.54M-2.87M-373.04K-46.1K-3.67M2.88M4.85M3.14M
Change in Receivables1.75M1.45M-732.83K-328.08K1.32M-955.23K-484.46K1.77M7K8.12K
Change in Inventory6.17M4M-3.5M-2.3M-2.76M1.31M-4.54M755.22K1.32M2.02M
Change in Payables177.06K654K489.01K-798.78K468.69K-973.86K1.63M384.93K3.49M203.25K
Cash from Investing-473.69K-58.45K-272.89K-425.76K-535.98K-733.47K-1.56M-1.28M-1.04M-498.78K
Capital Expenditures-473.87K-427.38K-272.89K-425.76K-535.98K-483.46K-1.56M-1.23M-953.58K-10.04K
CapEx % of Revenue1.54%1.47%1.01%1.32%1.84%1.23%3.62%4.11%4.34%-
Acquisitions025000000000
Investments----------
Other Investing175368.92K-28.09K-64.32K0-250K0-53.95K-84.32K-488.73K
Cash from Financing172.77K2.3K09.12M1.9M1.09M720.5K-451.81K2.3M-500K
Debt Issued (Net)0000965K0002.3M-500K
Equity Issued (Net)0001000K00-38.16K-451.81K00
Dividends Paid0000000000
Share Repurchases000000-38.16K-451.81K00
Other Financing172.77K2.3K063.75K932.48K1.09M758.66K000
Net Change in Cash
1.27M▲ 0%
2.15M▲ 69.9%
-2.83M▼ 231.6%
9.61M▲ 439.3%
1.61M▼ 83.2%
6.83M▲ 324.0%
-267.61K▼ 103.9%
-5.61M▼ 1996.5%
-6.1M▼ 8.8%
-8.93M▲ 0%
Free Cash Flow
1.09M▲ 0%
1.78M▲ 62.9%
-2.83M▼ 259.0%
491.04K▲ 117.3%
-286.79K▼ 158.4%
5.99M▲ 2188.5%
-988.11K▼ 116.5%
-5.16M▼ 422.1%
-8.32M▼ 61.3%
-5.46M▲ 0%
FCF Margin %3.56%6.11%-10.48%1.52%-0.98%15.27%-2.29%-17.23%-37.89%-34.65%
FCF Growth %-23.7%62.86%-259.02%117.33%-158.4%2188.5%-116.5%-422.07%-61.27%24.54%
FCF per Share0.540.85-1.330.22-0.101.98-0.32-1.70-2.74-2.74
FCF Conversion (FCF/Net Income)-0.16x-0.49x5.65x0.40x-0.04x0.51x0.24x0.20x0.51x0.46x
Interest Paid005412.2K884000015.77K
Taxes Paid0084.79K5.76K2.05K14.7K05.9K0-16.49K

CTHR Key Ratios

Charles & Colvard, Ltd. (CTHR) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201620172018201920202021202220232024TTM
Return on Equity (ROE)-24.56%-12.64%-1.3%5.65%-14.14%26.38%4.12%-39.42%-43.91%-62.7%
Return on Invested Capital (ROIC)-23.25%-11.13%-1.58%5.35%-15.01%12.08%5%-26.25%-37.66%-37.66%
Gross Margin33.2%30.06%42.77%46.18%27.37%46.96%46.98%15.81%23.65%16.78%
Net Margin-31.11%-15.52%-1.68%7.06%-21.11%32.65%5.51%-65.39%-65.42%-76%
Debt / Equity----0.06x0.07x0.06x0.07x0.17x0.17x
Interest Coverage-921.91x-2266.45x-1124.85x1030.74x-7144.49x615.21x---253.06x-85.54x
FCF Conversion-0.16x-0.49x5.65x0.40x-0.04x0.51x0.24x0.20x0.51x0.46x
Revenue Growth19.99%-5.2%-7.32%19.28%-9.47%34.42%9.82%-30.5%-26.68%-33.51%

CTHR Frequently Asked Questions

Charles & Colvard, Ltd. (CTHR) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Charles & Colvard, Ltd. (CTHR) reported $15.7M in revenue for fiscal year 2024. This represents a 15648% increase from $0.1M in 1997.

Charles & Colvard, Ltd. (CTHR) saw revenue decline by 26.7% over the past year.

Charles & Colvard, Ltd. (CTHR) reported a net loss of $12.0M for fiscal year 2024.

Dividend & Returns

Charles & Colvard, Ltd. (CTHR) has a return on equity (ROE) of -43.9%. Negative ROE indicates the company is unprofitable.

Charles & Colvard, Ltd. (CTHR) had negative free cash flow of $5.5M in fiscal year 2024, likely due to heavy capital investments.

Explore More CTHR

Charles & Colvard, Ltd. (CTHR) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.